More failure with solanezumab - this time in preclinical Alzheimer's disease
{{output}}
Introduction: There is no cure for Alzheimer's disease, which is the sixth leading cause of death in the USA. Lecanemab is anti-Aβ monoclonal antibody approved for the treatment of early Alzheimer's disease but is only marginall... ...
